EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Electrophoretically controlled dermal or transdermal application systems with electronic indicators


International Journal of Pharmaceutics (Kidlington) 36(1): 37-40
Electrophoretically controlled dermal or transdermal application systems with electronic indicators
The present investigation describes a system for the local application of basic drugs to the skin, using the antihistamine diphenhydramine hydrochloride as an example in which the release of the drug from a gel-type carrier is controlled by a weak electric field. In vitro studies of the release of drug showed that for example, through the application of 9 V, the amount of diphenhydramine hydrochloride released from a gel carrier in 5 min can be increased by a factor of 2.5. A newly developed, pencil-shaped application system contains an integrated voltage supply and an electronic indicator to show when the system is in operation. Investigations in 6 subjects of the current flow and electrical resistance of the human body show that the current through the body caused by the drug pencil is about 86 .mu.A.

Accession: 005349205

DOI: 10.1016/0378-5173(87)90233-X

Download PDF Full Text: Electrophoretically controlled dermal or transdermal application systems with electronic indicators



Related references

A review of the application of lipid-based systems in systemic, dermal/ transdermal, and ocular drug delivery. Critical Reviews in Therapeutic Drug Carrier Systems 25(6): 545-584, 2009

Adhesive binders for dermal or transdermal therapy systems. Official Gazette of the United States Patent & Trademark Office Patents 1234(3), May 16, 2000

Nanosized particulate systems for dermal and transdermal delivery. Journal of Biomedical Nanotechnology 6(6): 621-633, 2011

Pouch drug delivery systems for dermal and transdermal administration. Drug Delivery and Translational Research 4(5-6): 416-428, 2015

Application of microemulsions in dermal and transdermal drug delivery. Skin Pharmacology and Physiology 21(5): 246-259, 2008

Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems. Drug Delivery 20(5): 199-209, 2013

Dermal and transdermal drug delivery systems: current and future prospects. Drug Delivery 13(3): 175-187, 2006

Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Archives of Dermatological Research 303(9): 607-621, 2012

Phosphatidyl choline-based colloidal systems for dermal and transdermal drug delivery. Journal of Liposome Research 19(4): 267-277, 2010

Microstructured bicontinuous phase formulations: their characterization and application in dermal and transdermal drug delivery. Expert Opinion on Drug Delivery 10(8): 1043-1059, 2013